[Form 4] Apogee Enterprises Inc Insider Trading Activity

Rhea-AI Filing Summary

Apogee Enterprises Director Elizabeth Murphy Lilly received 2,954 deferred restricted stock units (RSUs) on June 25, 2025, as part of the company's 2019 Non-Employee Director Stock Plan. Following this transaction, Lilly beneficially owns 6,733 deferred RSUs.

Key transaction details:

• RSUs will convert to common stock on a 1-for-1 basis
• Settlement occurs upon director's Board termination or other specified events
• Total holdings include units acquired through dividend reinvestment
• Transaction price recorded as $0, as these are compensation awards

This Form 4 filing, executed by attorney-in-fact Meghan M. Elliott, demonstrates ongoing director compensation practices and alignment with shareholder interests through equity-based awards.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lilly Elizabeth Murphy

(Last) (First) (Middle)

C/O APOGEE ENTERPRISES, INC.

4400 WEST 78TH STREET, SUITE 520

(Street)

MINNEAPOLIS MN 55435

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
APOGEE ENTERPRISES, INC. [ APOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Restricted Stock Units(1)	(2)	06/25/2025		A		2,954		(1)	(1)	Common Stock	2,954	$0	6,733(3)	D

Explanation of Responses:

1. The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan.

2. Settled 1-for-1.

3. Includes deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan.

Remarks:

	/s/ Meghan M. Elliott, Attorney-in-Fact for Elizabeth Murphy Lilly	06/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many deferred restricted stock units did APOG director Elizabeth Murphy Lilly receive on June 25, 2025?

According to the Form 4 filing, Elizabeth Murphy Lilly received 2,954 deferred restricted stock units on June 25, 2025, under APOG's 2019 Non-Employee Director Stock Plan.

What is the total number of APOG deferred restricted stock units Elizabeth Murphy Lilly owns after this transaction?

Following the reported transaction, Elizabeth Murphy Lilly beneficially owns 6,733 deferred restricted stock units of APOG, which includes units acquired through dividend equivalent reinvestment features of the plan.

When will APOG director Elizabeth Murphy Lilly's restricted stock units be settled?

The deferred restricted stock units will be settled in shares of common stock following the director's termination from APOG's Board, in accordance with her election, or following other events specified in the 2019 Non-Employee Director Stock Plan.

What is the conversion ratio for APOG's deferred restricted stock units granted to Elizabeth Murphy Lilly?

The Form 4 filing indicates that the deferred restricted stock units are settled on a 1-for-1 basis, meaning each unit converts to one share of APOG common stock.